Navigation Links
New Study Shows 'No Medicare Savings' if Congress Moves Against Physician Owned Hospitals.
Date:12/17/2009

Entry," Contemporary Economic Policy In Press (2009).

(3) Payment levels are also adjusted for local wages (via the wage index) and overall patient acuity (via the case-mix index). For the purposes of this simple model, we ignore these because they are based on normalized indices as opposed to "add ons."

(4) There are a number of studies that have documented these differences. See generally GAO, "Comparative Analyses of Payments for Selected Hospital Services," in Report to the Subcommittee on Health, Committee on Ways and Means, House of Representatives (Washington, DC: U.S. General Accounting Office, 1990), S. Nicholson, "The Effects of Medicare Payment Subsidies to Teaching Hospitals," Leonard Davis Institute of Health Economics Issue Brief 7, no. 4 (2002).

(5) According to CMS, "Patients that have similar clinical characteristics and similar costs are assigned to an MS-DRG. The MS-DRG will be associated with a fixed payment amount based on the average cost of patients in the group. Patients are assigned to a MS-DRG based on diagnosis, surgical procedures, age and other information. Medicare uses this information that is provided by hospitals on their bill to decide how much they should be paid."

(6) Median Medicare payments for the same MS-DRG refers to the midpoint of all payments to the hospital for a particular MS-DRG (that is, half the payments were lower and half the payments were higher than the median payment).

(7) Calculation of median differences is weighted by caseload volume within MS-DRG. Differences are significant at p </= 0.05

(8) Adapted from www.cms.hhs.gov/acuteinpatientpps/02_stepspps.asp

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Molly Sandvig, JD

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=83748

SOURCE Physician Hospitals of America


'/>"/>
SOURCE Physician Hospitals of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. NIH awards La Jolla Institute $18.8 million for major infectious disease study
2. U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines
3. New study links DHA type of omega-3 to better nervous-system function
4. New Study Reveals Pistachios Have Anti-Inflammatory Properties
5. Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3%
6. Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results
7. UNC scientists coordinate study of link between insulin use and cancer in people with diabetes
8. Study finds significantly worse outcomes in cancer patients with cognitive impairment
9. IU study: Half of urban teen girls acquire STIs within 2 years of first sexual activity
10. Study finds over 90 percent of people with gum disease are at risk for diabetes
11. Study finds racial disparities exist in radiation therapy rates for early stage breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Sika Sarnafil , the worldwide market leader in ... Systems of Iowa as the Recycling Project of the ... the re-roofing of the SuperTarget retail store in Olathe, ... contractor and one of Target’s Preferred Tier One roofing ... building practices and they are a worthy recipient of ...
(Date:5/23/2013)... Professional Insurance Plans, an independent insurance ... celebrate Fibromyalgia Education and Awareness Month. As a ... country, the agency feels that it is important for ... that affects an estimated 10 million of Americans. , ... definition of Fibromyalgia (FM) is, “a common and complex ...
(Date:5/23/2013)... 23, 2013 Traditionally, laser skin therapy ... on skins of colour, this can be tricky. Based ... 1-1V may be treated safely with most lasers. Darker ... discoloration issues, have been left without recourse. Those who ... “clear” their skin successfully. , Hyperpigmentation occurs ...
(Date:5/23/2013)... , , THURSDAY, May 23 (HealthDay News) -- Statins are ... but the medications also could hamper heart patients, ability ... A small group of overweight or obese people ... taking a 40 milligram daily dose of simvastatin, while ... same exercise regimen did show improvement, found the study ...
(Date:5/23/2013)... PTSD , Soldiers returning home from combat may ... disorder if public support for a war effort is ... shapes the level of distress soldiers feel from the ... two experiments that asked participants to exterminate woodlice in ... actor show either interest or disgust for the act ...
Breaking Medicine News(10 mins):Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 3Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3
... Spanish . , The PhD, defended ... the Basque Country, proposes a series of recommendations that ... professionals who treat terminal cancer patients. , Autonomy is ... armed with knowledge about the causes of the illness, ...
... talk and ... care about digestive health, WHITE PLAINS, ... advertising campaign for Activia featuring award-winning,actress and passionate self-esteem advocate ... air throughout 2008, Curtis draws attention,to the importance of digestive ...
... Named National, Spokesperson for The Leukemia & Lymphoma Society,s 2008 Light The ... ... March 3 Rob Brown, who stars in the,upcoming drama The Express as ... to win the Heisman,Trophy, is the national spokesperson for The Leukemia & Lymphoma ...
... The Providence Service,Corporation (Nasdaq: PRSC ) today ... its fourth quarter and year ended December 31, 2007,on ... Providence will hold a conference call at 11:00 a.m. ... Thursday, March 13, 2008 to discuss its,financial results and ...
... CEL-SCI CORPORATION,(Amex: CVM ) provided details ... groundbreaking activities currently underway at its,manufacturing facility near ... Multikine(R), the Company,s lead compound, for a pivotal,Phase ... untreated head,and neck cancer patients. The facility, which ...
... ... Hospitals, TEL AVIV, ... digital templating software, will,launch its unique Orthoweb on-line service at the ... in San,Francisco (Booth #349, Hall A)., "This is a real ...
Cached Medicine News:Health News:Factors that enhance autonomy of cancer patients 2Health News:Factors that enhance autonomy of cancer patients 3Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 2Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 3Health News:Actor Rob Brown Rushes to Gain Ground Against Blood Cancer 2Health News:Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes 2Health News:Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes 3Health News:CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial 2Health News:Orthocrat to Launch On-Line Service for Storing and Sharing Pre-Operative Data at AAOS 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Therapeutics, Inc. (NASDAQ: HALO ) will be ... New York on Thursday, June 7, 2012 at 12:30 ... Financial Officer, Halozyme Therapeutics, will provide a corporate overview. ... The presentation will be webcast through the "Investors" section ...
... 31, 2012 /PRNewswire-iReach/ -- A January blog ... Institutes of Mental Health (NIMH), captured one of the core ... a divergence among members of the National Advisory Mental Health ... for funding by the NIMH. "Some members of ...
Cached Medicine Technology:Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference 2In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation 2In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation 3
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... coated with a thin layer ... the surface slick as glass ... prevent debris from collecting on ... For partial stenosis. Silicone with ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: